News | Pacemakers | May 24, 2018

Permanent Pacing Effective for Older Patients With Syncope and Bifascicular Block

Study finds significant advantages with permanent pacing versus an implantable cardiac monitor for particular patient group

Permanent Pacing Effective for Older Patients With Syncope and Bifascicular Block

May 24, 2018 — Syncope with bifascicular block may be caused by intermittent complete heart block, but competing diagnoses may coexist. A new study tested whether a strategy of empiric permanent pacing (PM) reduces major adverse events more effectively than acting on the results of an implantable cardiac monitor (ICM). Results of the study were presented at Heart Rhythm 2018, the 39th annual scientific sessions of the Heart Rhythm Society (HRS), May 9-12 in Boston.

In a multinational, randomized, pragmatic trial, 56 subjects under 50 years old with bifascicular block, preserved left ventricular function, and less than or equal to one syncope in the preceding year, received PM and 59 received an ICM. The primary outcome measure was a composite of Major Adverse Study-Related Events (MASRE), comprised of death, syncope, symptomatic bradycardia, asymptomatic actionable bradycardia and device complications.

The PM and ICM groups were similar in age, sex, lifetime syncopes, syncope in prior year, duration of symptoms, no prodrome and baseline systolic BP. Forty patients had left bundle branch block and 75 had right bundle branch block and a left hemiblock. Patients were followed for a median 30 months, and 21 exited the study — eight patients died, six withdrew consent after 2 years, four withdrew due to cancer and three due to dementia.

PM effectively prevented the primary outcome with end study MASRE-free survivals in PM (63 percent) and ICM (22 percent) group (p<0.001). The proportions of patients with syncope were similar in PM and ICM groups (27 vs 31 percent, p=0.50, Wilcoxon). Fully 35 out of 59 ICM patients (59 percent) crossed over to PM. There were five pacemaker complications requiring reintervention.

The researchers concluded that permanent pacing compared to ICM is a preferred strategy in elderly patients with few but recent syncopal spells and bifascicular block. This is driven by the high proportion of mildly symptomatic bradycardias detected on ICMs leading to pacemaker insertion.

For more information: www.hrssessions.org

Read more about HRS 2018 late-breaking studies

Related Content

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

News | Cardiovascular Clinical Studies | July 22, 2020
July 22, 2020 — Eating chocolate at least once a week is linked with a reduced risk of heart disease, according to re
The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

News | Cardiovascular Clinical Studies | January 20, 2020
January 20, 2020 — Scientists at Los Alamos and international partners have created the first 3-D images of a special
Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)
News | Cardiovascular Clinical Studies | December 23, 2019
Environmental and lifestyle issues were popular this year, with pick up from both...
News | Cardiovascular Clinical Studies | November 26, 2019
November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have sele
FDA Issues Final Guidance on Live Case Presentations During IDE Clinical Trials
News | Cardiovascular Clinical Studies | July 10, 2019
The U.S. Food and Drug Administration (FDA) issued the final guidance “Live Case Presentations During Investigational...
Veradigm Partners With American College of Cardiology on Next-generation Research Registries
News | Cardiovascular Clinical Studies | July 03, 2019
The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to power the next...
New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp